Beta Thalassemia-HBB Full Gene Analysis Single Test at DNA Labs UAE is a comprehensive genetic screening designed to identify mutations in the HBB gene, which is responsible for beta-thalassemia, a blood disorder that reduces the production of hemoglobin. Hemoglobin is the iron-containing protein in red blood cells that carries oxygen to cells throughout the body. Mutations in the HBB gene can lead to various forms of beta-thalassemia, ranging from mild to severe, affecting an individual's quality of life and requiring different management strategies.
This test is particularly valuable for individuals with a family history of beta-thalassemia or those belonging to ethnic groups with a high prevalence of the disease. It's also crucial for couples considering starting a family, as it can help assess the risk of passing the condition to their offspring.
Performed at the state-of-the-art DNA Labs UAE, the test involves a simple blood draw. The laboratory utilizes advanced genetic sequencing techniques to thoroughly analyze the HBB gene for any mutations that could lead to beta-thalassemia. The cost of the test is set at 1500 AED, making it an accessible option for those seeking comprehensive insights into their genetic health regarding beta-thalassemia.
Results from this test can provide crucial information for diagnosis, informing treatment plans, and making informed decisions about family planning. It is a valuable tool in the proactive management of beta-thalassemia, offering individuals and families peace of mind and the opportunity to plan for the future with greater certainty.
The "cKIT Mutation Screening Exons 9, 11, 13, 17 AML Test" is a specialized diagnostic assessment conducted to detect mutations in specific exons (9, 11, 13, and 17) of the cKIT gene. These mutations are significant because they can be implicated in the development of Acute Myeloid Leukemia (AML), a type of cancer that affects the blood and bone marrow. Identifying mutations in these exons helps in understanding the genetic basis of the disease, which can influence treatment decisions and prognosis.
This test is performed using advanced molecular techniques to analyze the patient's DNA for any alterations in the specified exons of the cKIT gene. It is crucial for patients diagnosed with or suspected to have AML, as it provides vital information that can guide personalized treatment strategies, potentially leading to better outcomes.
The test is available at DNA Labs UAE, a leading laboratory known for its state-of-the-art facilities and expertise in genetic testing. The cost of the test is set at 1500 AED, making it accessible to patients and healthcare providers in the region. By offering this test, DNA Labs UAE plays a crucial role in the early detection and management of AML, contributing to improved patient care and survival rates.
Cystic Fibrosis (CF) is a severe genetic disorder that primarily affects the lungs and digestive system due to the production of thick and sticky mucus. It is caused by mutations in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene. Among the numerous mutations identified, the most common ones include DelF508, G551D, G542X, and R553X. The "Cystic Fibrosis Mutation Screening CFTR - Del 508 G551D R553X G542X Test" is a comprehensive genetic test designed to detect these specific mutations in the CFTR gene.
This test is crucial for early diagnosis, which can significantly impact the management and treatment of cystic fibrosis. It is also valuable for family planning purposes, allowing potential parents to understand their risk of having a child with CF. Conducted at DNA Labs UAE, a leading facility in genetic testing, this screening ensures accuracy and reliability in results.
The cost of the test is 1500 AED, a worthwhile investment for individuals seeking detailed insights into their genetic predisposition to cystic fibrosis. By choosing to undergo this test at DNA Labs UAE, patients can expect state-of-the-art services, confidentiality, and professional guidance throughout the testing process.
The Prenatal Delta Beta-Thalassaemia Mutation Screening Test is a critical diagnostic tool offered by DNA Labs UAE, aimed at expecting parents who wish to assess the risk of their unborn child inheriting Delta Beta-Thalassemia. This condition is a form of thalassemia that affects the production of hemoglobin, leading to anemia and other health complications. The screening test specifically looks for mutations in the genes responsible for hemoglobin production, helping to predict the likelihood of the fetus developing this blood disorder.
Performed during pregnancy, this test provides vital information that can assist in planning for any necessary medical interventions or preparations. It is especially recommended for couples with a family history of thalassemias or those belonging to ethnic backgrounds with a higher prevalence of these conditions.
The cost of the Prenatal Delta Beta-Thalassaemia Mutation Screening Test at DNA Labs UAE is set at 1500 AED. This investment covers the sophisticated genetic analysis required to detect the presence of the mutations associated with the condition. Conducting the test in a reputable laboratory like DNA Labs UAE ensures accuracy and reliability of the results, offering peace of mind and essential health insights for expecting parents.
The DMD BMD Mutation Screening 26 Exons Test is a specialized genetic test conducted at DNA Labs UAE, designed to identify mutations in 26 specific exons of the DMD gene, which is responsible for Duchenne and Becker muscular dystrophies (DMD and BMD). These conditions are among the most common forms of muscular dystrophy, characterized by progressive muscle weakness and degeneration. Early and accurate detection of mutations in these exons can help in the diagnosis, management, and treatment planning for individuals affected by these disorders. The test is priced at 1500 AED, making it accessible for individuals seeking comprehensive genetic analysis in the UAE. DNA Labs UAE is equipped with advanced genetic testing facilities to ensure accurate and reliable results for patients and their families.
The EWSR1 Gene Ewing's Sarcoma Test is a sophisticated diagnostic procedure aimed at identifying the presence of specific genetic rearrangements associated with Ewing's sarcoma, a rare type of cancer that typically affects bones or the soft tissue around bones. This test focuses on detecting abnormalities in the EWSR1 gene, which are crucial for diagnosing the condition, determining prognosis, and guiding treatment decisions.
Performed at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing services, this test offers a reliable solution for patients and healthcare providers dealing with Ewing's sarcoma. The test cost is set at 1500 AED, reflecting the comprehensive analysis and expert interpretation involved in identifying the genetic markers associated with this aggressive cancer. By opting for this test, patients can gain valuable insights into their condition, enabling timely and targeted treatment interventions.
The FLT3ITD Allelic Ratio Test is a specialized genetic test designed to identify mutations in the FLT3 gene, specifically the internal tandem duplication (ITD) mutations, which are common in acute myeloid leukemia (AML) patients. This test plays a crucial role in the diagnosis, prognosis, and management of AML by determining the allelic ratio of the FLT3ITD mutation. The allelic ratio, which is the proportion of mutant FLT3 to wild-type FLT3, can influence treatment decisions and predict patient outcomes. A higher allelic ratio is often associated with a worse prognosis.
Conducted by DNA Labs UAE, a reputable laboratory known for its advanced genetic testing services, the FLT3ITD Allelic Ratio Test is priced at 1520 AED. The test is performed using sophisticated molecular techniques to ensure accurate and reliable results, which are essential for guiding the therapeutic approach and monitoring disease progression in AML patients. With its state-of-the-art facilities and expert staff, DNA Labs UAE provides a vital service to patients and healthcare providers, contributing to the personalized treatment of acute myeloid leukemia.
Fragile X Syndrome (FXS) is a genetic disorder that causes intellectual disability, behavioral challenges, and various physical characteristics. It is the most common form of inherited intellectual disability in males and a significant cause of intellectual disability in females. The disorder is linked to mutations in the FMR1 gene located on the X chromosome. These mutations lead to the production of an abnormal form of the protein needed for brain development.
The Polymerase Chain Reaction (PCR) test for Fragile X Syndrome is a specialized diagnostic tool used to detect the presence of mutations in the FMR1 gene. This test amplifies a small segment of the FMR1 gene's DNA, allowing for the examination of its structure and the identification of any abnormalities that indicate Fragile X Syndrome. The PCR test is known for its high sensitivity and specificity in detecting various types of mutations, including the number of CGG repeats in the FMR1 gene, which is crucial for diagnosing Fragile X Syndrome.
In the United Arab Emirates, DNA Labs UAE offers this sophisticated testing service. The cost of the Fragile X Syndrome FMR1 detection by PCR test at DNA Labs UAE is 1500 AED. This facility is equipped with state-of-the-art technology and staffed by experienced professionals who ensure accurate and reliable test results. Opting for this test at DNA Labs UAE can provide families with crucial information regarding Fragile X Syndrome, facilitating early diagnosis and the opportunity for timely intervention and support.
The Huntington Disease (HD) Mutation Screening Test is a crucial diagnostic tool available at DNA Labs UAE, designed to identify the presence of genetic mutations associated with Huntington's disease. Priced at 1600 AED, this test specifically looks for the expanded CAG repeats in the HTT gene, which are indicative of the disease. Huntington's disease is an inherited condition characterized by the progressive degeneration of nerve cells in the brain, leading to physical, cognitive, and emotional symptoms. Early detection through the HD Mutation Screening Test can be vital for individuals with a family history of the condition, enabling them to make informed decisions about their future health and lifestyle. DNA Labs UAE utilizes advanced genetic testing techniques to ensure accurate and reliable results, providing crucial information for the management and understanding of this challenging condition.
The IGVH Mutation Load Test is a sophisticated diagnostic procedure offered by DNA Labs UAE, aimed at patients with chronic lymphocytic leukemia (CLL). This test evaluates the mutational status of the immunoglobulin heavy chain variable region (IGHV) gene, which is crucial for predicting the disease's progression and guiding treatment strategies. A high mutation load in the IGVH gene is generally associated with a more favorable prognosis and may influence the choice of therapeutic approaches. Priced at 1600 AED, this test provides vital information for clinicians to tailor treatment plans more effectively, enhancing the potential for positive outcomes in CLL patients.
